ARK Investment Management 13F, Q2 2023
Cathie Wood · quarter ending 30 June 2023 · filed 10 July 2023 · SEC CIK 1697748
$15.10B
Filed US book
221
Positions
8.4%
Largest position
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q2 2023
The 25 largest of 221 positions. Weights are against the whole filed book.
| Company | Ticker | Value | % of book |
|---|---|---|---|
| Tesla Inc | TSLA | $1.27B | 8.4% |
| Coinbase Global Inc | COIN | $867.32M | 5.7% |
| UiPath Inc | PATH | $800.01M | 5.3% |
| Roku Inc | ROKU | $764.85M | 5.1% |
| Block Inc | XYZ | $714.09M | 4.7% |
| Zoom Video Communications Inc | ZM | $710.18M | 4.7% |
| Exact Sciences Corp | EXK | $671.86M | 4.5% |
| Shopify Inc | SHOP | $573.31M | 3.8% |
| Unity Software Inc | U | $518.25M | 3.4% |
| Teladoc Health Inc | TDOC | $515.11M | 3.4% |
| DraftKings Inc | DKNG | $479.87M | 3.2% |
| Twilio Inc | TWLO | $447.77M | 3.0% |
| CRISPR Therapeutics AG | $411.98M | 2.7% | |
| Intellia Therapeutics Inc | NTLA | $388.47M | 2.6% |
| ROBLOX Corp | RBLX | $375.54M | 2.5% |
| Pacific Biosciences of Califor | PACB | $354.24M | 2.4% |
| Robinhood Markets Inc | HOOD | $318.56M | 2.1% |
| Ginkgo Bioworks Holdings Inc | $315.73M | 2.1% | |
| Beam Therapeutics Inc | BEAM | $267.66M | 1.8% |
| PagerDuty Inc | PD | $233.34M | 1.5% |
| Veracyte Inc | VCYT | $199.39M | 1.3% |
| Schrodinger Inc/United States | SDGR | $175.59M | 1.2% |
| 10X Genomics Inc | TXG | $173.86M | 1.1% |
| Twist Bioscience Corp | TWST | $142.39M | 0.9% |
| Teradyne Inc | TER | $130.50M | 0.9% |
This is the earliest ARK Investment Management 13F we hold, so there is no earlier filing here to compare it with.
Other quarters
Source: SEC Form 13F-HR, accession 0001104659-23-079512, filed by ARK Investment Management LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.